The existing HIV medication Efavirenz may potentially also be effective for Alzheimer’s patients by lowering cholesterol in the brain. A clinical trial to test this led by Dr. Rik van der Kant, team leader at the Dementia Discovery, started in fall 2024 and now the first patient has completed treatment. Participants are still being recruited.
It has been known since 1936 that people diagnosed with schizophrenia are on average 1 centimeter shorter than people without that diagnosis. However, there have been few explanations of this relationship. Neuroscientist Cato Romero and his colleagues therefore investigated the link between schizophrenia and height in DNA datasets.
A study performed by PhD student Panthea Nemat of the Molecular Engrams team led by Dr. Priyanka Rao-Ruiz was recently published in a special issue on “Deciphering the memory engram” in Neurobiology of Learning and Memory in which they describe “Structural synaptic signatures of contextual memory retrieval-reactivated hippocampal engram cells”.
The CNCR focuses on the mechanistic understanding of gene function in the context of cognitive function.
We provide Neuroscience research training programs at Bachelor, Master, PhD and Postdoc levels
Follow us on X
